注明工作单位很正常,如果是做律师记者之类的,不标注根本就想不起谁是谁,每天接触太多人了。用短信不是电话,三种可能。一是不方便说话,对对方又很信任。二是她已经往少里说了,所以不觉得是什么秘密。三是她故意爆出来的。
睡重茶香 发表于 2/15/2020 3:30:56 AM [url=https://forums.huaren.us/showtopic.aspx?topicid=2505918&postid=82777777#82777777][img][/img][/url]
病毒在武汉两个月翻了万倍以上,美国现在没有足够的隔离措施,有上千例感染是很自然的推理
herbs 发表于 2/15/2020 7:19:55 AM [url=https://forums.huaren.us/showtopic.aspx?topicid=2505918&postid=82778029#82778029][img][/img][/url]
为啥关于中国的谣言大家都坚信是事实,关于美国的谣言大家就觉得就是谣言呢?我看cdc不作为的骚操作,这个谣言未必是谣言
Bellissima 发表于 2/14/2020 10:21:26 PM [url=http://forums.huaren.us/showtopic.aspx?topicid=2505918&postid=82775540#82775540][/url]
其实CDC做的没错 我早就说过,在特定时期为避免恐慌实行言论控制是没什么问题的
whitelephant 发表于 2/15/2020 9:42:31 AM
Nancy Messonnier ?那么容易搜到的名字?你们要不要去twitter问问她有没有说过这话
[url=https://rd2.huaren.us/huaren.php?hrtopic_id=2505918&hrurl=https%3a%2f%2ftwitter.com%2fDrNancyM_CDC]https://twitter.com/DrNancyM_CDC[/url]
富 发表于 2/14/2020 10:56:21 PM [url=https://forums.huaren.us/showtopic.aspx?topicid=2505918&postid=82775864#82775864][img][/img][/url]
Nancy Messonnier, MD, is the Director of the Center for the National Center for Immunization and Respiratory Diseases (NCIRD). Since beginning her public health career in 1995 as an Epidemic Intelligence Service Officer in the Deputy Director for Infectious Diseases (DDID), Dr. Messonnier has held a number of leadership posts across CDC and within NCIRD. She served as Deputy Director of NCIRD from October 2014-March 2016, and led the Meningitis and Vaccine Preventable Diseases Branch in NCIRD’s Division of Bacterial Diseases from 2007-2012.
Dr. Messonnier has provided critical leadership to CDC’s cross-cutting laboratory, global health, and surveillance initiatives. She has been a champion for prevention and control of bacterial meningitis in the United States—from drafting the initial recommendations for meningococcal polysaccharide vaccine use in those heading for college, to the introduction of meningococcal conjugate vaccines for routine use in teens. She also oversaw a family of studies exploring resurgence of pertussis in the United States and characterizing post-licensure effectiveness of acellular pertussis vaccines. She played a pivotal role in the successful public-private partnership to develop and implement a low cost vaccine to prevent epidemic meningococcal meningitis in Africa. More than 150 million people in the African Meningitis Belt have been vaccinated with MenAfriVac since 2010, with remarkable impact. Dr. Messonnier also has been a leader in CDC’s preparedness and response to anthrax, including during the 2001 intentional anthrax release and in evaluating simplified schedules for use of licensed anthrax vaccine.
Dr. Messonnier has written more than 140 articles and chapters and has received numerous awards. In 2011, she received NCIRD’s Philip Horne Award for unparalleled scientific contributions, exceptional mentorship, and staff development and in 2009 she received the Federal Executive Board’s Excellence in Action Outstanding Team award for the Anthrax Vaccine Research Program.
Dr. Messonnier received her BA from the University of Pennsylvania and MD from the University of Chicago School of Medicine. She completed internal medicine residency training at the University of Pennsylvania.